Taclonex and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Taclonex (betamethasone dipropionate; calcipotriene hydrate), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Flonase, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Taclonex. It is created by eHealthMe based on reports of 1,606 people who have side effects when taking Taclonex from the FDA, and is updated regularly.

What is Taclonex?

Taclonex has active ingredients of betamethasone dipropionate; calcipotriene hydrate. It is often used in psoriasis. eHealthMe is studying from 1,618 Taclonex users. Check the latest studies of Taclonex.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,436 drugs and 2,773 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

On Jul, 09, 2026

1,606 people reported to have side effects when taking Taclonex.
Among them, 37 people (2.3%) have Sinusitis - acute.

Among these 37 people:

How long have people been on Taclonex when they have Sinusitis - acute? *

What is the gender of people who have Sinusitis - acute when taking Taclonex? *

female: 64.86 %
male: 35.14 %

What is the age of people who have Sinusitis - acute when taking Taclonex? *

What are other drugs people take besides Taclonex? *

What are other side effects people have besides Sinusitis - acute? *

Upper Respiratory Tract Infection: 11 people, 29.73%
Nausea And Vomiting: 11 people, 29.73%
Otitis (ear infection): 10 people, 27.03%
Diarrhea: 10 people, 27.03%
Dehydration (dryness resulting from the removal of water): 8 people, 21.62%
Dizziness: 8 people, 21.62%
Respiratory Tract Infection: 8 people, 21.62%
Rhinovirus Infection: 8 people, 21.62%
Head Injury: 8 people, 21.62%
Gastric Ulcer (stomach ulcer): 7 people, 18.92%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 12 people, 32.43%
Combined Immunodeficiency: 9 people, 24.32%
High Blood Pressure: 4 people, 10.81%
Hypersensitivity: 2 people, 5.41%
Tinnitus (a ringing in the ears): 1 person, 2.70%
Thyroid Diseases: 1 person, 2.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.70%
Pain: 1 person, 2.70%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.70%
Multiple Allergies (allergy to multiple agents): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Taclonex and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taclonex:

Taclonex (1,618 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

How severe was Sinusitis - acute and when was it recovered:

Sinusitis - acute in Taclonex

Expand to all the drugs that have ingredients of betamethasone dipropionate; calcipotriene hydrate:

Sinusitis - acute and drugs with ingredients of betamethasone dipropionate; calcipotriene hydrate (185 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Taclonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,436 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,773 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone dipropionate; calcipotriene hydrate (the active ingredients of Taclonex) and Taclonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.